Business
AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest healthcare deal on record.
June 7, 2020
The board of directors of British drug maker AstraZeneca says it rejects the raised $119 billion takeover offer from U.S. drugmaker Pfizer.
May 19, 2014
AstraZeneca Plc, Europe’s largest drug maker, has lost an appellate court bid to force the U.S.
May 19, 2000
A federal court rejected a lawsuit seeking to force the Food and Drug Administration to rescind its approval of Sicor Inc.’
Aug. 14, 1999
World & Nation
The latest twist created another layer of uncertainty for a product already facing dwindling public support in Europe
March 24, 2021
American Vanguard Corp. said on Monday that its Amvac Chemical Corp. subsidiary has bought the Dacthal herbicide business from a British firm’s unit for an undisclosed price.
May 16, 2000
Science & Medicine
The funds will allow the company to conduct advanced human studies and establish manufacturing to deliver 100 million doses as soon as late 2020.
July 7, 2020
The U.K. has approved a second COVID-19 vaccine. AstraZeneca says it aims to supply millions of doses in the first quarter.
Dec. 30, 2020
Moderna says the trial has now enrolled 25,296 of an expected 30,000 volunteers, and more than 10,000 have received two doses of the vaccine.
Sept. 17, 2020
Nation Now
This article was originally on a blog post platform and may be missing photos, graphics or links.
Nov. 6, 2009